- Home
- MLAB vs CRMD Comparison
MLAB vs CRMD Comparison
Compare MLAB & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MLAB | CRMD |
|---|---|---|
| Founded | 1982 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 533.0M | 626.0M |
| IPO Year | 1995 | 2009 |
Fundamental Metrics
Financial Performance| Metric | MLAB | CRMD |
|---|---|---|
| Price | $96.80 | $8.77 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | ★ $94.00 | $14.83 |
| AVG Volume (30 Days) | 207.3K | ★ 1.5M |
| Earning Date | 05-27-2026 | 05-11-2026 |
| Dividend Yield | ★ 0.67% | N/A |
| EPS Growth | 436.11 | ★ 780.00 |
| EPS | ★ 1.21 | 0.43 |
| Revenue | N/A | ★ $311,709,000.00 |
| Revenue This Year | $6.07 | $0.30 |
| Revenue Next Year | $5.41 | N/A |
| P/E Ratio | $84.76 | ★ $20.44 |
| Revenue Growth | N/A | ★ 617.03 |
| 52 Week Low | $59.63 | $6.13 |
| 52 Week High | $113.99 | $14.96 |
Technical Indicators
Market Signals| Indicator | MLAB | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 44.55 | 58.94 |
| Support Level | $94.01 | $8.09 |
| Resistance Level | $97.56 | $9.03 |
| Average True Range (ATR) | 5.62 | 0.39 |
| MACD | 0.19 | 0.02 |
| Stochastic Oscillator | 46.24 | 84.34 |
Price Performance
Historical ComparisonAbout MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.